It has to be noted that the untreated CIDP patients in this study showed reduced FcγRIIb expression and the observed increase may have reflected a normalization of FcγRIIb expression levels upon reduction of overall inflammation by IVIg therapy. The gene discussed is FCGR2B; the disease is chronic inflammatory demyelinating polyradiculoneuropathy.